AI assistant
Sending…
Eton Pharmaceuticals, Inc. — Director's Dealing 2021
Jun 3, 2021
32663_dirs_2021-06-03_3282e9ad-cec7-46fb-859f-b6cec19a7f4c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Eton Pharmaceuticals, Inc. (ETON)
CIK: 0001710340
Period of Report: 2021-06-03
Reporting Person: BRYNJELSEN SEAN (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-03 | Common Stock | P | 5000 | $5.96 | Acquired | 1030000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 24940 | Indirect |
More from Eton Pharmaceuticals, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 9
Call Transcript
2026
Jun 4
Regulatory Filings
2026
May 19
Call Transcript
2026
May 14
Interim / Quarterly Report
2026
May 14
Earnings Release
2026
May 14
Regulatory Filings
2026
Apr 27
Board/Management Information
2026
Apr 16
Call Transcript
2026
Mar 19
Annual Report
2026
Mar 19